Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 10015-10023
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Table 5 Tumors other than gastrointestinal submucosal tumors
| No. of patient | Follow-up period, median (range), mo | Doubling time, median (range), mo | |
| Leiomyoma | 5 | 47.1 (10.7-137.2) | 231.2 (21.3-1303.8) |
| Schwannoma | 3 | 50.1 (24.3-71.7) | 104.7 (3.9-305.4) |
| Ectopic pancreas | 1 | 66.5 | 274.9 |
| Hamartoma | 1 | 99.6 | 61.2 |
| Intramural developmental cyst | 1 | 29.5 | 49.0 |
| Brunner’s adenoma | 1 | 30.6 | 134.7 |
- Citation: Koizumi S, Kida M, Yamauchi H, Okuwaki K, Iwai T, Miyazawa S, Takezawa M, Imaizumi H, Koizumi W. Clinical implications of doubling time of gastrointestinal submucosal tumors. World J Gastroenterol 2016; 22(45): 10015-10023
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/10015.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.10015